Rheumatoid Arthritis

Latest News

FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica
FDA Approves Sarilumab for Adults With Polymyalgia Rheumatica

March 1st 2023

Sarilumab is a fully human monoclonal antibody indicated for patients with polymyalgia rheumatica who had an inadequate response to corticosteroids or are unable to tolerate corticosteroid taper.

'Nocebo' Effect May Influence Outcomes After Switching to a Biosimilar
'Nocebo' Effect May Influence Outcomes After Switching to a Biosimilar

January 18th 2023

Biosimilar Shows Comparable Safety, Efficacy to Reference Product in Patients With RA
Biosimilar Shows Comparable Safety, Efficacy to Reference Product in Patients With RA

January 16th 2023

New Drug Delivery Method Could Replace Injections With Pills
New Drug Delivery Method Could Replace Injections With Pills

January 11th 2023

FDA Approves Adalimumab Biosimilar for Plaque Psoriasis, Other Chronic Conditions
FDA Approves Adalimumab Biosimilar for Plaque Psoriasis, Other Chronic Conditions

December 16th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.